Tesaro’s Zejula is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy.
America is the largest generic drugs market in the world.
The Seller/Buyer Offering Plan will match the interests of potential buyers to the pharmacy with customized, focused marketing via PRS's extensive network of buyers and contacts.
Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.
Merck KGaA and Pfizer's AMD Serono unit's Bavencio (avelumab) is intended for the treatment of adults and pediatric patients 12 years and older with MCC, including those who have not received prior chemotherapy.
Tobramycin Inhalation Solution USP, 300 mg/5 ml, a generic version of Novartis Pharmaceuticals’ TOBI 300 mg/5 ml, is indicated for the management of cystic fibrosis patients with P. aeruginosa.
The clomipramine hydrochloride capsules market had U.S. sales of approximately $172 million for the 12 months ending December 2016, according to IMS Health.
Newron Pharmaceuticals’ Xadago was approved as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.
Some of the difficult-to-treat conditions may include cancer, hepatitis B and C, HIV, rheumatoid arthritis and a host of other medical conditions requiring very specialized medications and therapy regimens.
Of the 62% of survey respondents who chose pharmacy over practitioner, most of the reasons hinged upon convenience.